e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment
O. Arkhipova, T. Martynyuk, L. Samoilenko, V. Sergienko, I. Chazova (Moscow, Russian Federation)
Source:
Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session:
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type:
Thematic Poster Session
Number:
2612
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Arkhipova, T. Martynyuk, L. Samoilenko, V. Sergienko, I. Chazova (Moscow, Russian Federation). Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment. Eur Respir J 2013; 42: Suppl. 57, 2612
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Quantitative estimation of lung perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Myocardial perfusion in patients with pulmonary hypertension of different etiology
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Lung perfusion: MRI vs SPECT for screening in suspected chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with CTEPH in the CHEST-1 study
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with PAH in PATENT-1
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Improved diagnostic accuracy of MRI in patients with suspected pulmonary hypertension with combined right ventricle and pulmonary artery metrics
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Estimation of mPAP with MRI in pulmonary hypertension subgroups: Comparison with echocardiography
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
About cardiac output assessment in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
LATE-BREAKING ABSTRACT: Peak oxygen consumption improves in inoperable, but not operable, chronic thromboembolic pulmonary hypertension after treatment with pulmonary arterial hypertension drugs
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013
Novel evaluation of pulmonary hypertension with chronic lung disease by perfusion SPECT/CT
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept